We sought to examine delayed-onset PTSD in a large multisite study
conducted with military veterans in primary care clinics. Using this sample we
had previously examined PTSD prevalence and correlates, reporting a PTSD
point-prevalence (current PTSD) of
11.5%,
15 current
subthreshold PTSD point-prevalence of
4.6%,
16 and that
veterans in the oldest group (age
![[gt-or-equal, slanted]](/corehtml/pmc/pmcents/ges.gif)
65, 6.3%) had one-third the PTSD
prevalence of those in the middle-aged group (ages 45–64, 18.6%),
despite higher rates of combat
exposure.
17
Post-traumatic stress disorder in this sample was positively associated with a
variety of comorbid psychiatric disorders, male gender, war zone service, age
<65 years, not working, less formal education and reduced
functioning.
15Given that PTSD symptoms may wax and wane over
time,
13 it was
deemed relevant to examine delayed onset of current PTSD symptoms that are
subsyndromal (i.e. `subthreshold PTSD') or now in remission (e.g. `lifetime
PTSD only'). Thus, in the present study we conducted new analyses with this
sample in order to address several important questions.
- Among veterans identified with PTSD, what is the prevalence of `delayed
onset'?
- Among veterans identified with current subthreshold PTSD and lifetime PTSD
only, what is the prevalence of `delayed onset'?
- Among veterans identified with delayed-onset current PTSD, subthreshold
PTSD and lifetime PTSD only, what does the time course of symptom onset look
like (e.g. are there cases of PTSD onset more than 5, 10, 20 years
post-trauma)?
- If rates of delayed-onset PTSD symptoms are high enough to permit
additional analyses, are there relevant predictors (e.g. ethnicity, age,
education) or correlates (e.g. other psychiatric symptoms or disorders, health
status, disability, healthcare service use) that can be identified?
Answers to these questions will carry implications for the evidence base
relevant to managing PTSD disability claims and clinical service needs.
Study design and procedures
Data were part of a larger cross-sectional study conducted on a random
sample of veterans at four US Veterans Affairs Medical Centers' primary care
clinics.
15 Study
participants were randomly selected from a master list of patients during the
fiscal year 1999 at each of the Veterans Affairs primary care sites.
Consenting participants were provided with a semi-structured clinic assessment
and within 2 months were administered a structured telephone interview by
master's-level clinicians trained and supervised by a licensed clinical
psychologist. Study measures were read aloud to all participants because many
were unable to read them because of vision problems or insufficient literacy
skills. Additionally, using available medical charts, we conducted a 12-month
retrospective review of each participant's Veterans Affairs treatment. Initial
exclusionary criteria included the presence of dementia-related symptoms, and
being age 80 or older. After providing a complete description of the study to
the participants, written informed consent was obtained. This study was
conducted with full approval from relevant institutional review boards.
Contact information of participants who completed on-site clinic
assessments was sent to the primary site, where clinicians (master's level and
above) telephoned them to administer structured interviews. The use of
telephone interviews of potential trauma victims to assess for traumatic event
exposure and PTSD symptoms, using a wide range of instruments, has been
relatively widespread in epidemiological research over the past 15
years,
18 with
strong psychometric properties and virtually no statistical differences in
rates of either trauma exposure or PTSD diagnoses when compared with
traditional face-to-face interviews, including samples of elderly
adults.
19Participants
A total of 1198 randomly identified veterans (known to be alive) were
approached for study participation. Of this sample, 885 veterans (74%)
provided an informed consent to participate during the clinic interview. As a
result of missing follow-up telephone interview data, our final sample was
reduced to 747 veterans. The average age (s.d.) of the final full sample
(n = 747) was 61.23 years (s.d. = 11.81), with a range from 25.50 to
81.12 years. Demographic characteristics for the sample are summarised in
.
| Table 1Demographic descriptors for participants in the full sample |
Conceptual definition of `delayed onset'
There is a notable lack of clarity regarding the conceptual definition of
`delayed onset'. Merely because a disorder is recognised many years after the
aetiological event is not evidence that onset of the disorder was `delayed'.
It has been noted that PTSD diagnosed more than 6 months after a traumatic
event may indicate delayed treatment or seeking of disability benefits,
delayed onset of any symptoms of PTSD (identified as `definition 1' by Andrews
et al)
1, or
delayed onset of the full disorder such that a change in one or two symptoms
alters PTSD diagnostic status (identified as `definition 2' by Andrews
et
al). Another issue is the actual time interval from traumatic exposure to
onset, with `delayed onset' counting as any PTSD onset that occurs from 7
months to 50 or more years post-trauma. Thus, there is definitional and
conceptual ambiguity in
DSM–IV
20 that
affects our understanding of delayed-onset PTSD. In fact, Spitzer
et
al3 have
proposed revised PTSD diagnostic criteria for DSM–V, changing the onset
criterion (criterion E) to read as either `the symptoms develop within a week
of the event' or `if delayed onset, the onset of symptoms is associated with
an event that is thematically related to the trauma itself (e.g., onset of
symptoms in a rape survivor when initiating a sexual relationship)'.
Measures
The Trauma Assessment for Adults – Self Report Version
(TAA)
21 assesses
the lifetime prevalence of trauma (both military and non-military) and has
been widely used to screen community and medical populations for trauma
history, finding trauma prevalence rates similar to those of other large-scale
studies.
22 This
survey provided data to categorise individuals as either meeting or failing to
meet DSM–IV PTSD's trauma exposure criterion A.
The Clinician Administered PTSD Scale
(CAPS)
23 was
administered to those participants who endorsed a traumatic event on the TAA.
The CAPS is a structured clinical interview that measures the intensity and
frequency of the 17 DSM–IV PTSD symptoms. The CAPS has excellent
psychometric properties and utility for making PTSD
diagnoses.
22 For
the present study, the CAPS was used to make classifications of current PTSD
and subthreshold PTSD. Participants were designated as having `current PTSD'
if they met criterion A on the TAA, and criteria B, C and D on the CAPS, with
clinically significant distress or impairment and a duration of all CAPS
symptoms greater than 1 month; the presence of symptoms was based on the
`frequency
![[gt-or-equal, slanted]](/corehtml/pmc/pmcents/ges.gif)
1/intensity
![[gt-or-equal, slanted]](/corehtml/pmc/pmcents/ges.gif)
2' CAPS scoring
rule.
23,24
For current subthreshold PTSD, the algorithm was based on a prior
definition,
25 which
requires endorsement of the criterion A and criterion B symptom clusters,
meeting diagnostic criteria for either the criterion C or criterion D symptom
cluster, and endorsement of clinically significant distress and impairment. A
mutually exclusive category for lifetime PTSD only was designated for those
who met PTSD criteria at some prior point in their life, but did not currently
meet criteria for the disorder or for subthreshold PTSD. Interrater
reliability analyses on a random sample of interviews (approximately 8%)
showed raters were 100% concordant for PTSD diagnoses on the CAPS.
Onset of PTSD symptoms was established via item 18 on the CAPS interview,
which inquires when the respondent first started having endorsed PTSD
symptoms, expressed in terms of the number of months after the index traumatic
event that symptoms started. Thus, this definition is consistent with Andrew
et al's
1
`definition 1' of delayed onset since it does not ask about full PTSD
criteria, but rather onset of any `PTSD symptoms'. As such, it represents a
conservative interpretation of the `delayed-onset' PTSD subtype. Also, as
recommended
1 we
express the rate of delayed-onset PTSD as the proportion of those with PTSD
(or subthreshold PTSD or lifetime PTSD only, as the case may be). This study
was designed so that it would have met Andrews
et al's criteria for
inclusion in their recent systematic review of prevalence studies on
delayed-onset PTSD.
Other measures and interviews included in the parent study of potential
relevance to the current study were the Short-Form Health Survey
(SF–36),
27
Post-Traumatic Stress Disorder Checklist – Civilian
(PCL–C),
28
and Mini International Neuropsychiatric Interview
(MINI).
29 We also
conducted an examination of electronic medical records for the 12 months
preceding study initiation for each consenting participant, via research
personnel masked to the diagnostic status of participants, which included
medical and psychiatric diagnoses/conditions and Veterans Affairs healthcare
service use in the year preceding study participation.
Overview of analytic strategies
Analyses were conducted with veterans in this sample to:
- identify prevalence of delayed-onset current PTSD;
- identify prevalence of delayed-onset `subthreshold PTSD' (based on
`current' symptoms) and `lifetime PTSD only' (past history of the disorder,
but not currently meeting criteria for either current PTSD or current
subthreshold PTSD);
- examine the time course of onset for current PTSD, subthreshold PTSD and
lifetime PTSD only in identified cases; and
- if cell sizes permitted, examine relevant predictors (e.g. ethnicity, age,
education) and correlates (e.g. other psychiatric symptoms or disorders,
health status, disability, healthcare service use) of delayed onset in order
to enhance our understanding of the phenomenon.